Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana.

Antiviral chemistry & chemotherapy - 1 Jan 2005

Bussmann Hermann, Novitsky Vladimir, Wester William, Peter Trevor, Masupu Kereng, Gabaitiri Lesego, Kim Soyeon, Gaseitsiwe Simane, Ndungú Thumbi, Marlink Richard, Thior Ibou, Essex Max

Abstract excerpt

Current HIV-1 antiretroviral (ARV) drug resistance knowledge is limited to HIV-1 subtype B (HIV-1B). We addressed whether unique genetic and phenotypic properties of HIV-1 subtype C (HIV-1C), southern Africa's most prevalent subtype, may foment earlier and/or distinct resistance mutations. Population-level HIV-1C genotypes were evaluated with respect to drug resistance prevalence before Botswana's public ARV...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Botswana

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Phylogeny

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 15889533
DOI: 10.1177/095632020501600203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana.PMID 15889533Read ↗

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana.Semantic proximity Read ↗

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.Semantic proximity Read ↗

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana.Semantic proximity Read ↗

Use of a mutation-specific genotyping method to assess for HIV-1 drug resistance in antiretroviral-naïve HIV-1 Subtype C-infected patients in BotswanaSemantic proximity Read ↗

HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.Semantic proximity Read ↗

Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana.Semantic proximity Read ↗

Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana.Semantic proximity Read ↗

Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.Semantic proximity Read ↗

Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.Semantic proximity Read ↗

HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.Semantic proximity Read ↗

Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.Semantic proximity Read ↗

HIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.